News & Presentations Filter by Category All 106 Company News 40 Media 23 Newsletter 9 Presentations & Webinars 36 Presentations & Webinars, All Michelle Long 5/2/26 Presentations & Webinars, All Michelle Long 5/2/26 Investor presentation Read More Presentations & Webinars, All Michelle Long 5/2/26 Presentations & Webinars, All Michelle Long 5/2/26 Euroz Hartleys 2026 Healthcare Forum presentation Read More Company News, All Michelle Long 5/2/26 Company News, All Michelle Long 5/2/26 Letter from Managing Director & CEO Read More Presentations & Webinars, All Michelle Long 4/2/26 Presentations & Webinars, All Michelle Long 4/2/26 Arovella speaking at ANZ Biologics Festival Read More Company News, All Michelle Long 29/1/26 Company News, All Michelle Long 29/1/26 Arovella’s IND for ALA-101 accepted by the U.S. Food and Drug Administration Read More Company News, All Michelle Long 30/12/25 Company News, All Michelle Long 30/12/25 Arovella files IND with the U.S. FDA for ALA-101 phase 1 clinical trial Read More Newsletter, All Michelle Long 26/11/25 Newsletter, All Michelle Long 26/11/25 Arovella Newsletter November 2025 Read More Presentations & Webinars, All Michelle Long 25/11/25 Presentations & Webinars, All Michelle Long 25/11/25 Monsoon AU CAR-T Showcase Read More Presentations & Webinars, All Michelle Long 18/11/25 Presentations & Webinars, All Michelle Long 18/11/25 Investor Presentation Read More Media, All Michelle Long 17/11/25 Media, All Michelle Long 17/11/25 The Australian biotechs racing toward the next billion dollar cancer drug Read More Company News, All Michelle Long 12/11/25 Company News, All Michelle Long 12/11/25 Arovella appoints former CSL CSO Dr Andrew Nash as Non-executive Director Read More Company News, All Michelle Long 5/11/25 Company News, All Michelle Long 5/11/25 ALA exercises Option for Baylor College of Medicine assets Read More Company News, All Michelle Long 30/10/25 Company News, All Michelle Long 30/10/25 AGM 2025 presentation and results Read More Company News, All Michelle Long 29/10/25 Company News, All Michelle Long 29/10/25 Arovella progresses ALA-101 program with appointment of phase 1 CRO Read More Company News, All Michelle Long 28/10/25 Company News, All Michelle Long 28/10/25 Positive FDA Type D Meeting Outcome Read More Presentations & Webinars, All Michelle Long 21/10/25 Presentations & Webinars, All Michelle Long 21/10/25 Dr Michael Baker presents at AusBiotech Invest 2025 Read More Presentations & Webinars, All Bradley Cocks 10/10/25 Presentations & Webinars, All Bradley Cocks 10/10/25 Dr Michael Baker’s presentation from the 2025 ASX SMIDcaps Conference Read More Company News, All Bradley Cocks 2/10/25 Company News, All Bradley Cocks 2/10/25 CLDN18.2 CAR-T cells eliminate pancreatic cancer cells Read More Company News, All Bradley Cocks 2/10/25 Company News, All Bradley Cocks 2/10/25 Notice of Annual General Meeting | Thursday 30 October 2025, 11:00 am AEDT Read More Presentations & Webinars, All Bradley Cocks 24/9/25 Presentations & Webinars, All Bradley Cocks 24/9/25 ALA presents at ASX SMIDcaps Conference Read More Older Posts
Presentations & Webinars, All Michelle Long 5/2/26 Presentations & Webinars, All Michelle Long 5/2/26 Investor presentation Read More
Presentations & Webinars, All Michelle Long 5/2/26 Presentations & Webinars, All Michelle Long 5/2/26 Euroz Hartleys 2026 Healthcare Forum presentation Read More
Company News, All Michelle Long 5/2/26 Company News, All Michelle Long 5/2/26 Letter from Managing Director & CEO Read More
Presentations & Webinars, All Michelle Long 4/2/26 Presentations & Webinars, All Michelle Long 4/2/26 Arovella speaking at ANZ Biologics Festival Read More
Company News, All Michelle Long 29/1/26 Company News, All Michelle Long 29/1/26 Arovella’s IND for ALA-101 accepted by the U.S. Food and Drug Administration Read More
Company News, All Michelle Long 30/12/25 Company News, All Michelle Long 30/12/25 Arovella files IND with the U.S. FDA for ALA-101 phase 1 clinical trial Read More
Newsletter, All Michelle Long 26/11/25 Newsletter, All Michelle Long 26/11/25 Arovella Newsletter November 2025 Read More
Presentations & Webinars, All Michelle Long 25/11/25 Presentations & Webinars, All Michelle Long 25/11/25 Monsoon AU CAR-T Showcase Read More
Presentations & Webinars, All Michelle Long 18/11/25 Presentations & Webinars, All Michelle Long 18/11/25 Investor Presentation Read More
Media, All Michelle Long 17/11/25 Media, All Michelle Long 17/11/25 The Australian biotechs racing toward the next billion dollar cancer drug Read More
Company News, All Michelle Long 12/11/25 Company News, All Michelle Long 12/11/25 Arovella appoints former CSL CSO Dr Andrew Nash as Non-executive Director Read More
Company News, All Michelle Long 5/11/25 Company News, All Michelle Long 5/11/25 ALA exercises Option for Baylor College of Medicine assets Read More
Company News, All Michelle Long 30/10/25 Company News, All Michelle Long 30/10/25 AGM 2025 presentation and results Read More
Company News, All Michelle Long 29/10/25 Company News, All Michelle Long 29/10/25 Arovella progresses ALA-101 program with appointment of phase 1 CRO Read More
Company News, All Michelle Long 28/10/25 Company News, All Michelle Long 28/10/25 Positive FDA Type D Meeting Outcome Read More
Presentations & Webinars, All Michelle Long 21/10/25 Presentations & Webinars, All Michelle Long 21/10/25 Dr Michael Baker presents at AusBiotech Invest 2025 Read More
Presentations & Webinars, All Bradley Cocks 10/10/25 Presentations & Webinars, All Bradley Cocks 10/10/25 Dr Michael Baker’s presentation from the 2025 ASX SMIDcaps Conference Read More
Company News, All Bradley Cocks 2/10/25 Company News, All Bradley Cocks 2/10/25 CLDN18.2 CAR-T cells eliminate pancreatic cancer cells Read More
Company News, All Bradley Cocks 2/10/25 Company News, All Bradley Cocks 2/10/25 Notice of Annual General Meeting | Thursday 30 October 2025, 11:00 am AEDT Read More
Presentations & Webinars, All Bradley Cocks 24/9/25 Presentations & Webinars, All Bradley Cocks 24/9/25 ALA presents at ASX SMIDcaps Conference Read More
